Skip to main content
Premium Trial:

Request an Annual Quote

TriLink Biotech Licenses dNTPs to Lucigen for Use in Hot Start Master Mix

Premium

TriLink Biotechnologies said today that it has licensed its CleanAmp dNTPs to Lucigen for use in its new PCR master mix.

Under the agreement, Lucigen will use the CleanAmp dNTPs in its Taq98 Hot Start 2X MasterMix. TriLink said that replacing standard dNTPs in a PCR assay with CleanAmp dNTPs can help achieve a hot start reaction, which in turn can help reduce mispriming, primer-dimer formation, and other common deleterious off-target effects in PCR.

"We have found that CleanAmp dNTPs improve the performance of a number of thermostable DNA polymerases, allowing for simple conversion of any assay to a hot start version," Natasha Paul, a scientific investigator with TriLink, said in a statement.

Lucigen's new Taq98 Hot Start 2X Master Mix is designed for customers seeking to amplify difficult DNA templates, including targets with greater than 70 percent GC content. The product is expected to be available for sale in mid-August.

"We believe Taq98 represents a great combination of performance, ease-of-use, and value for the customer," Lucigen President Jeff Williams said in a statement. "The addition of the hot start feature has significantly increased the market for this product."

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.